Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evalyn E A P Mulder

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
The New England Journal of Medicine|January 18, 2023
Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for VitiligoJoséphine C Janssen, Evalyn E A P Mulder, Astrid A M van der Veldt
Surgical Endoscopy|October 19, 2016
Ergonomics in the operating roomShiromani Janki, Evalyn E A P Mulder, Jan N M IJzermans, et al.
European Journal of Cancer (Oxford, England : 1990)|July 18, 2025
Letter Re: Patient-reported outcomes with adjuvant nivolumab versus placebo after complete resection of stage IIB/C melanoma in the randomized phase 3 CheckMate 76 K trialBrigit van Dijk, Joséphine C Janssen, Evalyn E A P Mulder, et al.
Transplantation|February 21, 2018
3D Endoscopic Donor Nephrectomy Versus Robot-assisted Donor Nephrectomy: A Detailed Comparison of 2 Prospective CohortsEvalyn E A P Mulder, Shiromani Janki, Türkan Terkivatan, et al.
European Journal of Cancer (Oxford, England : 1990)|September 23, 2021
Adjuvant treatment in patients with melanoma: The planning of scanningEvalyn E A P Mulder, Dirk J Grünhagen, Stefan Sleijfer, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 8, 2016
Five-year follow-up after live donor nephrectomy - cross-sectional and longitudinal analysis of a prospective cohort within the era of extended donor eligibility criteriaShiromani Janki, Leonienke F C Dols, Reinier Timman, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 31, 2023
Clinical evaluation of the clinicopathologic and gene expression profile (CP-GEP) in patients with melanoma eligible for sentinel lymph node biopsy: A multicenter prospective Dutch studyRobert C Stassen, Evalyn E A P Mulder, Antien L Mooyaart, et al.
Cancer Cell|July 15, 2022
Immune suppression in the tumor-draining lymph node corresponds with distant disease recurrence in patients with melanomaAnneloes van Krimpen, Vivian I V Gerretsen, Evalyn E A P Mulder, et al.
Journal of Surgical Oncology|July 8, 2021
False positive FDG uptake in melanoma patients treated with talimogene laherparepvec (T-VEC)Evalyn E A P Mulder, Emma H A Stahlie, Daniëlle Verver, et al.
Annals of Diagnostic Pathology|February 12, 2022
Mesenchymal-epithelial transition factor (MET) immunoreactivity in positive sentinel nodes from patients with melanomaEvalyn E A P Mulder, Daniëlle Verver, Thom van der Klok, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
The New England Journal of Medicine|January 18, 2023
Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for VitiligoJoséphine C Janssen, Evalyn E A P Mulder, Astrid A M van der Veldt
Surgical Endoscopy|October 19, 2016
Ergonomics in the operating roomShiromani Janki, Evalyn E A P Mulder, Jan N M IJzermans, et al.
European Journal of Cancer (Oxford, England : 1990)|July 18, 2025
Letter Re: Patient-reported outcomes with adjuvant nivolumab versus placebo after complete resection of stage IIB/C melanoma in the randomized phase 3 CheckMate 76 K trialBrigit van Dijk, Joséphine C Janssen, Evalyn E A P Mulder, et al.
Transplantation|February 21, 2018
3D Endoscopic Donor Nephrectomy Versus Robot-assisted Donor Nephrectomy: A Detailed Comparison of 2 Prospective CohortsEvalyn E A P Mulder, Shiromani Janki, Türkan Terkivatan, et al.
European Journal of Cancer (Oxford, England : 1990)|September 23, 2021
Adjuvant treatment in patients with melanoma: The planning of scanningEvalyn E A P Mulder, Dirk J Grünhagen, Stefan Sleijfer, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 8, 2016
Five-year follow-up after live donor nephrectomy - cross-sectional and longitudinal analysis of a prospective cohort within the era of extended donor eligibility criteriaShiromani Janki, Leonienke F C Dols, Reinier Timman, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 31, 2023
Clinical evaluation of the clinicopathologic and gene expression profile (CP-GEP) in patients with melanoma eligible for sentinel lymph node biopsy: A multicenter prospective Dutch studyRobert C Stassen, Evalyn E A P Mulder, Antien L Mooyaart, et al.
Cancer Cell|July 15, 2022
Immune suppression in the tumor-draining lymph node corresponds with distant disease recurrence in patients with melanomaAnneloes van Krimpen, Vivian I V Gerretsen, Evalyn E A P Mulder, et al.
Journal of Surgical Oncology|July 8, 2021
False positive FDG uptake in melanoma patients treated with talimogene laherparepvec (T-VEC)Evalyn E A P Mulder, Emma H A Stahlie, Daniëlle Verver, et al.
Annals of Diagnostic Pathology|February 12, 2022
Mesenchymal-epithelial transition factor (MET) immunoreactivity in positive sentinel nodes from patients with melanomaEvalyn E A P Mulder, Daniëlle Verver, Thom van der Klok, et al.
Pageof 2